Tuesday, January 28, 2014

Pfizer Q4 and Full Year Report 2013

PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2013 RESULTS;
PROVIDES 2014 FINANCIAL GUIDANCE

  • Fourth-Quarter 2013 Reported Revenues of $13.6 Billion (13.9), Full-Year 2013 Reported Revenues of $51.6 Billion (54.7).
  • Fourth-Quarter 2013 Adjusted Diluted EPS of $0.56 (0.46), Reported Diluted EPS of $0.39 (0.89), Full-Year 2013 Adjusted Diluted EPS of $2.22 (2.10), Reported Diluted EPS(1) of $3.19 (1.94).
  • Repurchased $4.6 Billion and $16.3 Billion of Common Stock in Fourth-Quarter and Full-Year 2013, Respectively; Returned Approximately $23 Billion to Shareholders Through Share Repurchases and Dividends in 2013.

Pfizer's 2014 financial guidance:

  • Adjusted Revenues: $49.2 to $51.2 billion
  • Reported Diluted EPS: $1.57 to $1.72
  • Adjusted Diluted EPS: $2.20 to $2.30


For more information, click the link below
Pfizer Q4-2013

3 comments:

  1. Greetings Hawk! I was surprised earnings came in as strong as they did. I sold last year because I wanted to raise some cash, but I think management is generally doing the right things. You can't fault the dividend, and with a 26% payout it should continue to climb. I wonder if they will spin off any more divisions?

    Would you mind changing your blogger comment settings to allow "name/url"? I would appreciate it. Have a great day
    -Bryan

    ReplyDelete
    Replies
    1. Hi Bryan! Surprised me also. Those future spin off, time will show! Settings changed, hopefully will work now, good day for you too.
      DH

      Delete